Skip to main content

Day: July 1, 2020

Equity consortium closes acquisition of stakes in New York’s Astoria Energy facilities

BIRMINGHAM, Ala., July 01, 2020 (GLOBE NEWSWIRE) — Harbert Power Fund III, LLC (“HPF II”), Harbert Power Fund V, LLC (“HPF V”) and NM Harbert Astoria LLC (“Harbert Astoria”) are pleased to announce their participation in the sale of 100% of the holdings in Astoria Power Partners LLC (“APP”) and approximately 55% of the holdings in Astoria Power Partners II LLC (“APP II” together, the “Platform”) to a newly formed holding company, Astoria Power Partners Holding, LLC (“APPH”).The selling owners of APP include ENGIE, Mitsui & Co, Harbert Power Fund III, LLC, Harbert Power Fund V, LLC, JEMB Family L.P., and funds managed by Ares EIF Management, LLC, and selling owners in APP II include ENGIE, Harbert Power Fund III, LLC, JEMB Family L.P., NM Harbert Astoria LLC, and TIAA.APPH, the buyer, is comprised of a consortium of equity investors...

Continue reading

Fluidra reaches a deal to acquire Aquafive

The global leader in the pool and wellness equipment business reaches a deal to acquire the Belgium based distributor of pool products.The purchase price places the equity value of Aquafive at approximately 4.8 million euros, with an immediate payment of 3.3 million euros and three annual deferred payments of 0.5 million euros.1st July 2020 – Fluidra, the global leader in the pool and wellness equipment business, has acquired one hundred percent of the capital of the Belgian distributor of pool products Aquafive. Both companies share a longstanding relationship in the past, Aquafive being the exclusive distributor of Zodiac branded products distributing in the Benelux region.The purchase price places the equity value of Aquafive, and its subsidiary Pentagone, at approximately 4.8 million euros. The price will be settled by an initial...

Continue reading

Middlesex Water Company Named a Top New Jersey Workplace

ISELIN, N.J., July 01, 2020 (GLOBE NEWSWIRE) — Middlesex Water Company (NASDAQ: MSEX), a provider of water, wastewater and related services, announced today it has been selected as one of the Top Workplaces in New Jersey by NJ.com. The list of top New Jersey workplaces is based solely on employee feedback gathered through a third-party survey administered by employee engagement technology partner Energage, LLC. The anonymous survey uniquely measures 15 drivers of engaged cultures, which are critical to the success of any organization—including alignment, execution and connection.“In times of great change, it is more important than ever to maintain a connection among employees,” said Eric Rubino, Energage CEO. “When you give your employees a voice, you come together to navigate challenges and shape your path forward based on real-time...

Continue reading

Crossject : Fin du programme de conversion des OC émises en 2019

Communiqué de PresseFin du programme de conversiondes OC émises en 2019 Dijon, le 1er juillet  2020CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe et commercialisera prochainement un portefeuille de médicaments dédiés aux situations d’urgence, annonce la fin du programme de conversion des obligations convertibles (OC) émises en  décembre 2019.Les obligations convertibles émises en décembre 2019 ont été intégralement converties. Ces conversions ont permis à Crossject de renforcer ses fonds propres pour un montant de 5,7 M€ par création de 3 680 612 actions.La conversion de la totalité des OC avant son terme, initialement prévu au 31 décembre 2021, illustre une nouvelle fois la confiance des investisseurs européens qui avaient souscrit à cette émission, et de Gemmes Venture, par ailleurs actionnaire historique...

Continue reading

[iliad] Communiqué établissant le bilan semestriel du contrat de liquidité entre ILIAD et NATIXIS ODDO BHF

Société anonyme au capital de 13 113 261,52 eurosSiège social : 16, rue de la Ville l’Evêque – 75008 Paris342 376 332 R.C.S. PARIS                                                                            Paris, le 1er juillet 2020Communiqué établissant le bilan semestrieldu contrat de liquidité entre ILIAD et NATIXIS ODDO BHFAu titre du contrat de liquidité confié par ILIAD à NATIXIS ODDO BHF, à la date du 30/06/2020 les ressources suivantes figuraient au compte de liquidité dédié :Il est rappelé qu’à la date de signature du contrat, les ressources suivantes figuraient au compte de liquidité dédié :Sur la période du 02 /01/2020 au 30 /06/2020 ont été exécutés :Sur cette même période, les volumes échangés ont représenté :A propos du Groupe iliadLe Groupe iliad est devenu en 20 ans un acteur majeur des télécommunications en France...

Continue reading

Albion Venture Capital Trust PLC: Annual Financial Report

               Albion Venture Capital Trust PLCLEI number: 213800JKELS32V2OK421As required by the UK Listing Authority’s Disclosure Guidance and Transparency Rules 4.1 and 6.3, Albion Venture Capital Trust PLC today makes public its information relating to the Annual Report and Financial Statements for the year ended 31 March 2020.This announcement was approved for release by the Board of Directors on 1 July 2020.This announcement has not been audited.The Annual Report and Financial Statements for the year ended 31 March 2020 (which have been audited), will shortly be sent to shareholders. Copies of the full Annual Report and Financial Statements will be shown via the Albion Capital Group LLP website by clicking www.albion.capital/funds/AAVC/31Mar2020.pdf.The information contained in the Annual Report and Financial Statements will...

Continue reading

Form 8.3 – Cello Health plc

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1.         KEY INFORMATION2.         POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should...

Continue reading

Industrial Gases Market to Reach USD 149.33 Billion by 2027; Owing to Rising Demand from Healthcare and Pharmaceutical Sector, says Fortune Business Insights™

Pune, July 01, 2020 (GLOBE NEWSWIRE) — The global industrial gases market size is anticipated to showcase notable growth in the forecast years on account of the increasing demand from the oil and gas industry worldwide. Industrial gases are used across various applications such as food & beverage, oil and gas, petrochemicals, healthcare, chemicals, and others. As per a recent report by Fortune Business Insights, titled, “Industrial Gases Market Size, Share and Industry Analysis, By Gas Type (Oxygen, Nitrogen, Carbon Dioxide, Hydrogen, Argon, and Others), By Application (Packaging, Coolant, Carbonation, Cryogenic, Cutting & Welding, Laboratory, Air Separation, and Others), By End User (Metallurgy, Healthcare, Chemical, Food & Beverage, Oil & Gas, Power, Pulp and Paper, Electronics, Water Treatment, Mining, and...

Continue reading

Sandoz reviewing options after Federal Circuit upholds lower court ruling in biosimilar Erelzi® case

Sandoz evaluating next steps, including potential appeal to US Supreme Court Ruling continues to prevent launch of important, affordable treatment option for US patients affected by chronic autoimmune and inflammatory diseases Sandoz remains deeply committed to making Erelzi available to US patients as soon as possible, contributing to a more sustainable healthcare systemHolzkirchen, Germany, July 1, 2020 – Sandoz, a Novartis division and a global leader in biosimilars, today announced that the US Court of Appeals for the Federal District has ruled against Sandoz in patent litigation concerning the Sandoz biosimilar Erelzi® (etanercept-szzs) for reference medicine Enbrel®* (etanercept).Today’s decision upholds a prior ruling from the New Jersey District Court, which declared the Amgen patents valid. Sandoz is evaluating its options, which...

Continue reading

Pinnacle Dermatology, a Chicago Pacific Founders portfolio company, Appoints Judson Larson as Chief Financial Officer

Lombard, IL, July 01, 2020 (GLOBE NEWSWIRE) — Pinnacle Dermatology, a rapidly growing dermatology practice headquartered in Lombard, IL is pleased to announce that Judson Larson has joined its Executive Leadership team as Chief Financial Officer.“We are thrilled to have Judson Larson join the Pinnacle Dermatology Executive Leadership Team,” said Chad A. Eckes, Pinnacle Dermatology Chief Executive Officer. “Judd has spent much of his career in healthcare administration finance roles including private equity backed healthcare organizations.  He brings extensive operational and financial experience along with a proven track record of meeting strategic objectives by driving and managing growth, maintaining productivity, controlling cost, and enhancing profitability. “Mr. Larson last served as Chief Financial Officer of Omni Ophthalmic...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.